Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Targeting the CB 2 receptor and other endocannabinoid elemen — 2021 Review/Other | BudProfiles

Home

Studies

Targeting the CB 2 receptor and other endocannabin...

PositiveReview/Other2021

Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Amyotrophic Lateral Sclerosis (ALS)

Related Studies

Inconclusive

Use of non-medical cannabis in epilepsy: A scoping review

2023·Review/Other

Positive

What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?

2022·Review/Other

Positive

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

2022·Meta-analysis -

Positive

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents

2022·Review/Other

Positive

Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

2022·Animal Study - Veterinary Clinical Trial

Positive

The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?

2022·Review/Other

Cannabinoids

Synthetic Cannabinoid (unspecified)Endocannabinoid (unspecified)

Organ Systems

Nervous System

Study Details

Type: Review/Other
Year: 2021
Study ID: #20211243